-- Throughout the past years, Creative Bioarray has consistently provided outstanding professional products and services to help clients conduct research in a timely manner. Various research and analysis demonstrate the breadth and expertise as well as the ability to deliver research results in a timely manner and with great confidence. Recently, Creative Bioarray is proud to announce the availability of a comprehensive portfolio of well-established and customized disease models designed to support the preclinical efficacy evaluation of therapeutic candidates. With robust experience in disease modeling, Creative Bioarray is always committed to enhancing drug development processes through proven expertise and tailored solutions.
Creative Bioarray boasts a team of dedicated scientists who work closely with clients to ensure the recommendation of the most clinically relevant in vivo models for target indications, covering a broad range of therapeutic areas. From autoimmune and metabolic diseases to oncology and neurological disorders, Creative Bioarray designs translational models aimed at reducing pipeline risk and accelerating drug development.
“Whether you need standardized research protocols or fully customized model installations, Creative Bioarray will be a trusted partner, providing you with high-quality, reproducible efficacy data,” said Hannah Cole, the marketing director of Creative Bioarray. “We are committed to scientific collaboration and innovative solutions that help researchers advance treatment discoveries and ultimately benefit patients.”
Creative Bioarray supports a diverse portfolio of disease models, encompassing a wide range of validated disease models. In oncology, patient-derived xenograft (PDX) and cell line-derived xenograft (CDX) models can be used to evaluate the efficacy of novel cancer therapies. For autoimmune diseases, customizable models, such as those for rheumatoid arthritis and multiple sclerosis, enable in-depth studies of treatment effects.
“We also offer metabolic disease models, including models for type 1 and type 2 diabetes, obesity, and hyperuricemia, helping researchers understand key disease mechanisms. Furthermore, models for neurological diseases such as Alzheimer's and Parkinson's are designed to facilitate drug testing and elucidate their underlying mechanisms.” said Hannah Cole, she also claimed, “We have a dedicated team of scientific experts ready to assist clients in customizing models to meet specific research needs, ensuring that the selected model accurately reflects clinical conditions. All developed models are designed to provide high-quality, reproducible data, which is crucial for informed decision-making in drug development.”
Creative Bioarray recognizes the challenges of translation from laboratory to clinic. Its advanced disease models not only mimic human diseases but also deliver reliable results to inform clinical decision-making. These models help companies accelerate the time to market for important therapies. Whether you need standardized research protocols or want to develop fully customized models, Creative Bioarray is committed to satisfying the needs of every client and providing tailored solutions for unique research requirements.
About Creative Bioarray
Creative Bioarray has established and validated various animal models in an array of therapeutic areas. Our expertise, skill level, and the quality of the data that we produce is now widely recognized by scientists throughout the global pharmaceutical and biopharmaceutical industry.
Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: Shirley, NY 11967, USA
Phone: 16313868241
Website: https://www.creative-bioarray.com/
Release ID: 89177262
Google
RSS